CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 23 enrolled
Drug / intervention
NutraStem +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01847027
NCT01847027Phase 2Completed

Phase 2 Study of the Effect of a Nutritional Supplement and Exercise on Human Stem Cells

University of North Texas Health Science Center·interventional·Posted May 6, 2013·Updated May 29, 2019

In Brief

A Phase 2 clinical trial evaluating NutraStem and Placebo for Adult Stem Cell Proliferation. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The purpose of this study is to see if an investigational supplement called NutraStem® will increase the amount of stem cells in human blood at rest and after exercise. The ingredients found in NutraStem® can be found in nutrition or vitamin shops/stores.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 6, 2013
Enrollment StartApr 1, 2013
Primary CompletionJul 17, 2017
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 13.2 years ago

Interventions

NutraStemdrug

Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress. Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.

Placebodrug

Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.